Ulta Beauty
ULTA
$564.44
+0.09%
Ulta Beauty is the largest specialized beauty retailer in the United States, operating over 1,500 freestanding stores that offer a comprehensive assortment of cosmetics, fragrances, skin care, and hair care products, complemented by in-store salon services. The company's distinct competitive identity is built on its one-stop-shop destination model, combining mass and prestige brands under one roof, which has solidified its market leadership and strong customer loyalty. The current investor narrative is dominated by concerns over margin pressure and rising costs, as evidenced by a sharp stock decline following its Q4 2025 earnings report, despite beating top and bottom-line estimates; this has sparked a debate about the company's ability to navigate inflationary pressures and maintain its historically strong profitability in a potentially slowing consumer environment.…
ULTA
Ulta Beauty
$564.44
Related headlines
Investment Opinion: Should I buy ULTA Today?
Rating: Hold. The core thesis is that Ulta's strong fundamentals are currently overshadowed by near-term margin and momentum risks, creating a 'show me' story where the stock is likely to remain range-bound until profitability trends clarify.
Supporting evidence includes a forward P/E of 17.55x which prices in a recovery, solid Q4 revenue growth of 11.78%, and exceptional financial health shown by $985.6M in TTM FCF and a 41.14% ROE. However, these positives are counterbalanced by the technical breakdown (-16.60% over 3 months), margin compression (Q4 gross margin of 38.06%), and a valuation (trailing P/E of 25.2x) that remains elevated relative to its own history.
The thesis would upgrade to Buy if the forward P/E compresses further toward 15x on sustained earnings growth, or if the company demonstrates consecutive quarters of gross margin stabilization above 39%. It would downgrade to Sell if revenue growth decelerates below 8% or if operating margins contract below 11%. Currently, the stock appears fairly valued relative to its near-term challenges but undervalued relative to its long-term structural strengths.
Sign up to view all
ULTA 12-Month Price Forecast
Ulta presents a classic 'GARP' (Growth at a Reasonable Price) dilemma caught between strong structural attributes and deteriorating near-term momentum. The forward P/E is compelling, but only if the assumed earnings rebound materializes. The stance is neutral due to the high uncertainty around margin trajectory, which the next 1-2 quarters will critically clarify. An upgrade to bullish would require evidence that the Q4 margin compression was an anomaly, not a trend. A downgrade to bearish would be triggered by a breakdown below the $516 support level on high volume, signaling a failure of the base-case stabilization scenario.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ulta Beauty's 12-month outlook, with a consensus price target around $733.77 and implied upside of +30.0% versus the current price.
Average Target
$733.77
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$452 - $734
Analyst target range
Analyst coverage for ULTA appears limited in the provided dataset, with only 5 analysts contributing to the estimates for revenue and EPS, which is insufficient to derive a robust consensus price target or recommendation distribution. The lack of a comprehensive analyst target price and rating breakdown in the data suggests coverage may be sparse or the data feed is incomplete. This limited coverage, for a company of Ulta's market cap ($29 billion), is unusual and could indicate that the available dataset is not capturing the full institutional research landscape; in practice, Ulta is widely covered. The implications of potentially limited or fragmented analyst coverage include the possibility of higher volatility and less efficient price discovery, as fewer professional opinions are formally guiding the market. The available institutional ratings from recent dates show a mix of 'Overweight,' 'Outperform,' and 'Buy' actions from firms like Morgan Stanley, JP Morgan, and Oppenheimer, alongside one 'Underweight' from Wells Fargo, indicating a generally bullish skew among those providing recent commentary, but a definitive consensus cannot be quantified from the provided data points.
Bulls vs Bears: ULTA Investment Factors
The investment debate for Ulta Beauty is currently balanced but tilting bearish in the near term due to overwhelming focus on margin erosion. The bull case rests on the company's unassailable market position, robust cash generation, and resilient demand, all of which are supported by strong ROE and FCF metrics. The bear case, however, is powerfully evidenced by the stock's severe technical breakdown and the market's punitive reaction to margin concerns, despite a revenue and earnings beat. The single most important tension is whether Ulta's 11.78% revenue growth can sustainably offset inflationary cost pressures and protect its net margin, which has already compressed from prior-year levels. The resolution of this margin trajectory will determine if the stock's forward P/E of 17.55x is a value trap or a compelling entry point.
Bullish
- Dominant Market Position & Loyalty: As the largest specialized beauty retailer in the U.S. with over 1,500 stores, Ulta's one-stop-shop model combining mass and prestige brands creates a powerful competitive moat. This is reflected in its exceptionally high return on equity of 41.14%, demonstrating efficient capital use and strong brand loyalty.
- Robust Free Cash Flow Generation: The company generates substantial internal cash, with TTM free cash flow of $985.6 million. This provides significant financial flexibility to fund growth, execute share buybacks, and navigate economic cycles without straining its moderate balance sheet, which has a debt-to-equity ratio of 0.78.
- Healthy Revenue Growth Trajectory: Despite recent volatility, Ulta delivered solid 11.78% year-over-year revenue growth in its latest Q4 2025, reaching $3.90 billion. This indicates underlying demand for its product and service mix remains resilient in the face of consumer spending concerns.
- Attractive Forward Valuation: The stock's forward P/E of 17.55x represents a significant discount to its trailing P/E of 25.17x, implying the market has already priced in a meaningful earnings recovery. This forward multiple offers a more compelling entry point if the company can meet or exceed earnings estimates of $43.01 EPS.
Bearish
- Severe Margin Pressure & Cost Inflation: The sharp post-earnings stock decline was driven by investor focus on rising costs, overshadowing a top and bottom-line beat. Q4 2025 gross margin of 38.06% was below the full-year figure of 39.10%, signaling quarterly compression that threatens the company's historically strong profitability profile.
- Valuation at Upper Historical Range: The trailing P/E of 25.2x is above the stock's own historical range, which has fluctuated between approximately 12x and 20x in recent years. Trading near the upper end of this band suggests the stock was priced for perfection and is now vulnerable to further multiple compression if growth normalizes.
- Significant Technical Breakdown & Weak Momentum: The stock is down 16.60% over the past 3 months, severely underperforming the SPY's +2.67% gain, and sits at only 77% of its 52-week range after a 27.83% maximum drawdown. This indicates a major loss of momentum and a breakdown from its previous uptrend, with key support near $516 recently tested.
- Macro Sensitivity & Stagflation Fears: As a consumer cyclical stock with a beta of 0.95, Ulta is exposed to a slowing economic environment. Recent news highlights reviving stagflation fears, which could pressure discretionary spending on beauty products and further compress margins, challenging the Fed's policy path and market optimism.
ULTA Technical Analysis
The prevailing price trend for ULTA has been one of significant volatility within a wide range, culminating in a sharp correction from recent highs. The stock's 1-year price change of +54.68% indicates a strong longer-term uptrend, but the current price of $553.36 sits at approximately 77% of its 52-week range ($350.10 to $714.97), suggesting it has retreated meaningfully from its peak and is now in a consolidation phase following a steep decline. Recent momentum shows a stark divergence from the longer-term trend, with the stock down -16.60% over the past 3 months and up only +6.28% over the past month; this 3-month underperformance, especially against a +2.67% gain for the SPY, signals a significant loss of momentum and a potential trend reversal or deep correction from the early 2026 highs. Key technical levels are clearly defined by the 52-week high of $714.97 as major resistance and the 52-week low of $350.10 as substantial support; a breakdown below the recent March low near $516 could signal further downside, while reclaiming the $686 level is needed to suggest a recovery is underway. The stock's beta of 0.953 indicates volatility roughly in line with the broader market, but the recent price action, including a maximum drawdown of -27.83%, highlights periods of intense stock-specific selling pressure, which investors must factor into risk management.
Beta
0.95
0.95x market volatility
Max Drawdown
-27.8%
Largest decline past year
52-Week Range
$375-$715
Price range past year
Annual Return
+49.4%
Cumulative gain past year
| Period | ULTA Return | S&P 500 |
|---|---|---|
| 1m | +9.6% | +8.5% |
| 3m | -17.7% | +2.8% |
| 6m | +9.0% | +4.6% |
| 1y | +49.4% | +32.3% |
| ytd | -9.0% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ULTA Fundamental Analysis
Ulta's revenue trajectory remains positive but shows signs of normalization from peak growth rates. The most recent quarterly revenue (Q4 2025 ending Jan 31, 2026) was $3.90 billion, representing a solid year-over-year growth of 11.78%. However, examining sequential quarterly revenues from the provided income statements ($2.85B in Q3, $2.79B in Q2, $2.85B in Q1) shows revenue dipped in the middle quarters of fiscal 2025 before a strong seasonal rebound in Q4, indicating some volatility in the growth pattern rather than steady acceleration. The company remains solidly profitable, with net income of $356.7 million in Q4 2025 and a trailing twelve-month net margin of 9.31%. Gross margin for the quarter was 38.06%, which is below the full-year gross margin of 39.10% indicated in the valuation data, suggesting some quarterly compression; operating margin was 12.43%, aligning closely with the full-year operating margin of 12.50%. The balance sheet and cash flow position is healthy, supporting financial flexibility. The company generated robust free cash flow of $985.6 million on a TTM basis, providing ample internal funding for growth and shareholder returns. The debt-to-equity ratio is a manageable 0.78, indicating a moderate use of leverage, while the current ratio of 1.41 demonstrates sufficient short-term liquidity. The return on equity is exceptionally strong at 41.14%, highlighting efficient use of shareholder capital, though this is supported by share buybacks which reduce equity.
Quarterly Revenue
$3.9B
2026-01
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$985555000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ULTA Overvalued?
Given Ulta's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 25.17x and a forward PE of 17.55x based on estimated EPS. The significant gap between the trailing and forward multiples implies the market expects a substantial rebound in earnings growth, with forward estimates pricing in improved profitability. Compared to sector averages, Ulta's valuation presents a mixed picture; its trailing PE of 25.2x is above the typical market average for specialty retail, though a direct industry average from the provided data is not available for comparison. The premium is likely justified by the company's dominant market position, high returns on equity (41.14%), and strong free cash flow generation, but is being tested by near-term margin concerns. Historically, the stock's own valuation provides critical context: the current trailing PE of 25.2x is above the historical range visible in the data, which shows PE ratios fluctuating between approximately 12x and 20x over recent years (e.g., 12.1x in Jan 2025, 20.3x in Jan 2026). Trading near the upper end of its own historical band suggests the market had priced in very optimistic expectations, and the recent correction represents a re-rating as those expectations are recalibrated for a more challenging cost environment.
PE
25.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 12x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on profitability sustainability. Ulta's Q4 2025 gross margin of 38.06% shows sequential compression, and its net margin of 9.31% (TTM) is below the prior year's Q4 net income ratio. The company's high return on equity of 41.14% is partly fueled by share buybacks, making it sensitive to earnings volatility. While debt is moderate at a 0.78 debt-to-equity ratio, the primary risk is that continued margin pressure erodes the premium valuation justified by its historical profitability, necessitating a growth slowdown to fund cost controls.
Market & Competitive Risks are heightened by valuation and macro factors. Trading at a trailing P/E of 25.2x, above its own historical range, Ulta faces significant valuation compression risk if earnings growth fails to accelerate. Its beta of 0.953 indicates market-correlated volatility, but the -19.27% 3-month relative strength versus the SPY shows intense stock-specific selling. The looming end of its Target partnership in summer 2026 presents a near-term revenue risk, while broader stagflation fears threaten consumer discretionary spending across its product categories.
Worst-Case Scenario involves a protracted consumer downturn coupled with unrelenting cost inflation, leading to consecutive quarters of margin misses and guidance reductions. This could trigger a re-rating to the lower end of its historical P/E range (around 12x) and a test of its 52-week low of $350.10. From the current price of $553.36, this scenario implies a potential downside of approximately -37%. A more immediate adverse scenario could see the stock break below recent support near $516, leading to a swift decline toward the $450-$475 range as momentum sellers exit.
FAQ
The key risks, in order of severity, are: 1) Margin Erosion: Q4 2025 gross margin of 38.06% shows compression; sustained pressure could derail earnings growth. 2) Valuation Compression: A trailing P/E of 25.2x is vulnerable to de-rating if growth slows. 3) Consumer Cyclicality: As a discretionary retailer (beta 0.95), Ulta is exposed to economic downturns and stagflation fears, which could hurt same-store sales. 4) Partnership Loss: The wind-down of the Target revenue partnership in summer 2026 presents a near-term traffic and sales risk that must be managed.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $525 and $600 as margins stabilize and earnings meet the $43.01 consensus, supported by strong cash flow. The Bull Case (25% probability) could drive the stock back toward its 52-week high between $686 and $715 on successful cost management and resilient consumer spending. The Bear Case (15% probability) risks a drop to between $350 and $475 if margin pressure intensifies and a consumer slowdown materializes. The base case is most likely, hinging on the assumption that inflation pressures moderate without causing a recession.
ULTA's valuation is mixed, presenting a fair price for its current risk profile. The trailing P/E of 25.2x is above its own historical range (approx. 12x-20x), suggesting the market had priced in optimistic growth that is now being questioned. However, the forward P/E of 17.55x, based on a $43.01 EPS estimate, implies the market expects a meaningful earnings rebound and offers a more attractive multiple. Compared to sector averages, Ulta often trades at a premium justifi ed by its market leadership and high returns. Currently, the stock is fairly valued, balancing strong fundamentals against significant near-term execution risks.
ULTA is a good buy for patient, long-term investors comfortable with near-term volatility, but not for short-term traders. The forward P/E of 17.55x offers a reasonable entry point if you believe in the company's ability to stabilize margins and grow into its valuation. However, with the stock down 16.60% over 3 months and facing clear margin headwinds, timing is crucial. It is a higher-risk proposition for those seeking immediate gains, but the underlying business quality—evidenced by 41.14% ROE and nearly $1B in FCF—makes it a compelling hold-and-wait candidate for portfolios with a multi-year horizon.
ULTA is primarily suitable for a long-term investment horizon of 3-5 years. Its business model and market leadership are structural advantages that take time to compound, but the near-term path is clouded by margin uncertainty and technical weakness. The stock's beta of 0.95 and lack of a dividend make it less ideal for short-term trading or income-seeking investors. Given the current 'show me' story, a minimum holding period of 12-18 months is suggested to allow for the margin narrative to clarify and for the company to demonstrate its post-Target partnership strategy.